首页 > 市场调查报告书 > 医疗设备

避孕器市场规模、份额和成长分析（按产品类型、技术、分销管道和地区划分）－2026-2033年产业预测

市场调查报告书

商品编码

1896838

避孕器市场规模、份额和成长分析（按产品类型、技术、分销管道和地区划分）－2026-2033年产业预测

Contraceptive Devices Market Size, Share, and Growth Analysis, By Product Type, By Technology, By Distribution Channel, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月17日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格

简介目录

预计到 2024 年，避孕器市场规模将达到 318.3 亿美元，到 2025 年将达到 337.6 亿美元，到 2033 年将达到 540.5 亿美元，在预测期（2026-2033 年）内，复合年增长率为 6.06%。

由于各方努力减少意外怀孕和医疗费用，以及使用者意识的提高，避孕器市场预计将会成长。政府和医疗机构主导的各项计划旨在推广计划生育，并加强避孕器的生产和分销。私营部门和公共部门都对避孕器供应链做出了重要贡献，其中私营部门主要专注于避孕套和避孕药等短效避孕方法，占据了相当大的市场份额。在某些地区，相当一部分女性从私人机构取得避孕器，而其他女性则依赖公共服务。青少年的综合性宣传活动和教育计画对于推广避孕器、预防性性行为感染和意外怀孕至关重要，并得到了许多知名健康组织的大力支持。

避孕器市场驱动因素

避孕器市场的一项重大进展是高效无激素避孕器（IUD）的问世。这项创新技术为女性提供可靠且持久的避孕方式。 IUD采用独特的设计，注重安全性和易用性，确保了无痛的避孕体验，同时降低了副作用的风险。其高效性和易用性使其成为寻求便捷可靠避孕方式的女性的理想选择。这项进展标誌着生殖健康选择范围扩大，以满足世界各地女性多样化需求和偏好的重要转折点。

避孕器市场限制

避孕器市场面临一些挑战，这些挑战可能会阻碍其成长潜力。成本上升、某些器械可能引发的併发症以及地区监管差异等因素可能会限制避孕产品的可及性和消费者接受度。此外，文化偏见和关于生殖健康的误解可能会阻碍人们寻求这些选择。某些族群对避孕的抗拒也可能影响市场接受度。此外，其他避孕方法的普及可能会加剧市场竞争，因此，持续创新和消费者教育对于製造商保持强大的市场地位至关重要。

避孕器市场趋势

避孕器市场受多种因素影响显着增长，包括意外怀孕率上升和人们对计划生育方法的认识提高。性行为感染感染（STI）的日益普及以及政府对计划生育倡议的大力支持进一步推动了市场扩张。从保险套到长效植入多种避孕方法的普及，加上可支配收入的增加，提高了避孕产品的可近性。此外，电子商务平台的蓬勃发展、创新避孕方案的研发以及消费者对非荷尔蒙和自然避孕方法的偏好转变（尤其是那些显着偏向女性的主导方法），都反映了消费者偏好的变化，并有效地推动了市场发展。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前五大公司对比
主要企业的市场定位（2025 年）
主要市场参与者所采取的策略
近期市场趋势
公司市占率分析（2025 年）
主要企业公司简介
- 公司详情
- 产品系列分析
- 依业务板块进行公司股票分析
- 2021-2023年营收年比比较

主要企业简介

Bayer AG（Germany）
Pfizer Inc.（US）
Janssen Global Services, LLC（US）
Teva Pharmaceutical Industries Ltd.（Israel）
Merck Sharp & Dohme Corp.（US）
Mylan NV（US）
Reckitt Benckiser Group plc.（UK）
Veru Inc.（US）
Medisafe Distribution Inc.（Canada）
CooperSurgical, Inc.（US）
Devex（US）
Mayer Laboratories, Inc.（US）
Allergan plc（Ireland）
Agile Therapeutics（US）
HLL Lifecare（India）
Ansell Ltd（Australia）
Mankind Pharma（India）
TTK HealthCare（India）
Boehringer Ingelheim International GmbH.（Germany）
V-Care Pharma Pvt. Ltd.（India）

结论与建议

简介目录

Product Code: SQMIG35I2253

Contraceptive Devices Market size was valued at USD 31.83 Billion in 2024 and is poised to grow from USD 33.76 Billion in 2025 to USD 54.05 Billion by 2033, growing at a CAGR of 6.06% during the forecast period (2026-2033).

The contraceptive devices market is set to experience growth driven by initiatives aimed at minimizing unintended pregnancies and healthcare expenditures while increasing user awareness. Various programs led by governments and healthcare organizations advocate for family planning and enhance the production and distribution of contraceptives. Both private and public sectors significantly contribute to the contraceptive supply chain, with the private sector focusing on short-acting methods such as condoms and pills, capturing a substantial market share. In certain regions, a notable percentage of women source contraceptives from private providers, while others depend on public services. Comprehensive campaigns and educational programs targeting younger demographics are crucial for promoting contraceptive use and preventing both STDs and unintended pregnancies, supported by vital contributions from renowned health organizations.

Top-down and bottom-up approaches were used to estimate and validate the size of the Contraceptive Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Contraceptive Devices Market Segments Analysis

Global Contraceptive Devices Market is segmented by product type, technology, distribution channel and region. Based on product type, the market is segmented into male contraceptive devices, female contraceptive devices, female condoms, diaphragms & sponges, vaginal rings, intrauterine devices, sub-dermal implants and others. Based on technology, the market is segmented into hormonal contraceptives and barrier contraceptives. Based on distribution channel, the market is segmented into hospital pharmacy, retail pharmacy, clinics, online channels, public channel & ngo and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Contraceptive Devices Market

A significant advancement in the contraceptive devices market is the introduction of a highly efficient, non-hormonal intrauterine device (IUD). This innovative technology presents women with a dependable and enduring form of birth control. Featuring a unique design that emphasizes safety and user-friendliness, this IUD ensures a seamless contraceptive experience while reducing the likelihood of side effects. Its effectiveness and ease of use position it as an attractive option for women in search of convenient and reliable contraception. This development represents a pivotal shift toward more options in reproductive health, catering to the diverse needs and preferences of women worldwide.

Restraints in the Contraceptive Devices Market

The Contraceptive Devices market faces certain challenges that can hinder its growth potential. Factors such as rising costs, potential complications associated with some devices, and varying regulations across different regions can limit accessibility and consumer adoption. Additionally, cultural stigmas and misinformation surrounding reproductive health may discourage individuals from seeking out these options. Resistance from certain groups, who may view contraceptive use unfavorably, can also impact market acceptance. Furthermore, the availability of alternative birth control methods may lead to increased competition, making it essential for manufacturers to continuously innovate and educate consumers to maintain a strong foothold in the market.

Market Trends of the Contraceptive Devices Market

The Contraceptive Devices market is experiencing significant growth driven by various factors, including rising rates of unintended pregnancies and a growing awareness of family planning methods. Increased prevalence of sexually transmitted infections (STIs) and heightened governmental support for family planning initiatives further catalyze market expansion. The diverse availability of contraceptive options, ranging from condoms to long-acting implants, along with rising disposable incomes, enhances accessibility. Additionally, the surge in e-commerce platforms, development of innovative contraceptive solutions, and a noticeable shift towards non-hormonal and natural methods reflect evolving consumer preferences, particularly towards female-controlled options, effectively propelling the market forward.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Analysis
Patent Analysis
Case Study Analysis
Startup Analysis

Global Contraceptive Devices Market Size by Product Type & CAGR (2026-2033)

Market Overview
Male Contraceptive Devices
Female Contraceptive Devices
Female Condoms, Diaphragms & Sponges
Vaginal Rings
Intrauterine Devices
Sub-Dermal Implants
Others

Global Contraceptive Devices Market Size by Technology & CAGR (2026-2033)

Market Overview
Hormonal Contraceptives
Barrier Contraceptives

Global Contraceptive Devices Market Size by Distribution Channel & CAGR (2026-2033)

Market Overview
Hospital Pharmacy
Retail Pharmacy
Clinics
Online Channels
Public Channel & Ngo
Others

Global Contraceptive Devices Market Size & CAGR (2026-2033)

North America (Product Type, Technology, Distribution Channel)
- USA
- Canada
Europe (Product Type, Technology, Distribution Channel)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product Type, Technology, Distribution Channel)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product Type, Technology, Distribution Channel)
- Brazil
- Rest of Latin America
Middle East & Africa (Product Type, Technology, Distribution Channel)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

Bayer AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pfizer Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Janssen Global Services, LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Teva Pharmaceutical Industries Ltd. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck Sharp & Dohme Corp. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mylan N.V. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Reckitt Benckiser Group plc. (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Veru Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medisafe Distribution Inc. (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CooperSurgical, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Devex (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mayer Laboratories, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Allergan plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agile Therapeutics (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
HLL Lifecare (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ansell Ltd (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mankind Pharma (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
TTK HealthCare (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boehringer Ingelheim International GmbH. (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
V-Care Pharma Pvt. Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments